PTC THERAPEUTICS, INC. Annual Net Cash Provided by (Used in) Financing Activities in USD from 2014 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
Ptc Therapeutics, Inc. quarterly/annual Net Cash Provided by (Used in) Financing Activities history and growth rate from 2014 to 2023.
  • Ptc Therapeutics, Inc. Net Cash Provided by (Used in) Financing Activities for the quarter ending March 31, 2024 was $540K, a 86.8% decline year-over-year.
  • Ptc Therapeutics, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2023 was $646M, a 285% increase from 2022.
  • Ptc Therapeutics, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2022 was $168M, a 704% increase from 2021.
  • Ptc Therapeutics, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2021 was $20.9M, a 96.9% decline from 2020.
Net Cash Provided by (Used in) Financing Activities, Annual (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $646M +$478M +285% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-29
2022 $168M +$147M +704% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-29
2021 $20.9M -$648M -96.9% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-29
2020 $669M +$55.5M +9.05% Jan 1, 2020 Dec 31, 2020 10-K 2023-02-21
2019 $613M +$482M +366% Jan 1, 2019 Dec 31, 2019 10-K 2022-02-22
2018 $132M +$87.4M +198% Jan 1, 2018 Dec 31, 2018 10-K 2021-02-25
2017 $44.2M +$43.3M +4468% Jan 1, 2017 Dec 31, 2017 10-K 2020-03-02
2016 $968K -$153M -99.4% Jan 1, 2016 Dec 31, 2016 10-K 2019-03-01
2015 $154M -$83.1M -35% Jan 1, 2015 Dec 31, 2015 10-K 2018-03-06
2014 $237M Jan 1, 2014 Dec 31, 2014 10-K 2017-03-16
* An asterisk sign (*) next to the value indicates that the value is likely invalid.